Prophylaxis: Clinical Trials

2 trials for Prophylaxis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Prophylaxis: new trials by email Literature Review of Prophylaxis trials Research Report on Prophylaxis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
Truvada alone, Truvada plus Leuprolide 11.25mg intramuscular injection, Truvada plus Estradiol 1 mg - HIV, Prophylaxis
Phase 1CompletedJohns Hopkins University132021-03-012026-04-06
Mesenchymal Stem Cells for the Treatment of COVID-19
PrimePro, Placebo - Covid19, Prophylaxis
Phase 1CompletedThomas Advanced Medical LLC402020-04-242020-10-05

Narrower conditions

COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

Emtricitabine (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Estradiol (1)  ·  Estrogens (1)  ·  Injections, Intramuscular (1)  ·  Leuprolide (1)  ·  Single Person (1)  ·  Tenofovir (1)

Sponsors

Johns Hopkins University (1)  ·  Thomas Advanced Medical LLC (1)

Countries

United States (2)

Top investigators

Ernst R Von Schwarz, MD, PhD (1)  ·  Mark A Marzinke, PhD (1)

NIH funding

R01AI145675 (1)